Completing the present picture of a broad and mechanistically diverse involvement of the melastatin subfamily channels in the prostate cancer development, TRPM2 is one more known member that controls proliferation of prostate cancer cells by inhibiting the nuclear ADP-ribosylation [147]. This evidence concerns the gene TRPM2 and prostate cancer.